Finerenone reduces heart failure events in patients with HFpEF
1. In this randomized controlled trial of patients with heart failure and mildly decreased or preserved ejection fraction, finerenone treatment ...
1. In this randomized controlled trial of patients with heart failure and mildly decreased or preserved ejection fraction, finerenone treatment ...
1. Cardiovascular death and first heart failure hospitalization was reduced among HFrEF patients compared to HFmrEF and HFpEF patients. 2. ...
1. Patients assigned to hemodynamic monitoring reported improved quality of life than those receiving contemporary guideline-directed medical therapy. 2. The ...
1. In this decision analytical model study among 4.8 million adults with heart failure in the United States, optimal implementation ...
1. Amongst patients with HFrEF, lower socioeconomic status was associated with increased rates of HFrEF readmission and all-cause mortality, even ...
1. SGLT-2 inhibitors reduced time to first hospitalization and cardiovascular death among patients with preserved, mildly reduced, and reduced ejection ...
1. A prediction of the long-term effects of dapagliflozin from the short-term data in the Dapagliflozin and Prevention of Adverse-Outcomes ...
1. Hypertension, diabetes, smoking, atrial fibrillation, and previous myocardial infarction were associated with a higher risk of incident heart failure ...
1. Receiving medications from a greater number of drug classes is linked to lower incidence of rehospitalization and death, for ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.